VitroScan is dedicated to delivering predictive diagnostic testing to support better informed treatment decisions for cancer patients.
VitroScan has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in November 2024.
VitroScan's investors include Biotech Booster.
VitroScan is headquartered in Leiden, The Netherlands.
VitroScan is dedicated to delivering predictive diagnostic testing to support better informed treatment decisions for cancer patients.
VitroScan is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VitroScan — Funding & Investors." VCBacked, November 25, 2024, https://www.vcbacked.co/company/vitroscan. Accessed August 14, 2026.
VCBacked. (2024). VitroScan — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vitroscan
{{cite web |title=VitroScan — Funding & Investors |url=https://www.vcbacked.co/company/vitroscan |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated